全文获取类型
收费全文 | 224篇 |
免费 | 17篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 9篇 |
基础医学 | 25篇 |
口腔科学 | 9篇 |
临床医学 | 17篇 |
内科学 | 46篇 |
皮肤病学 | 7篇 |
神经病学 | 5篇 |
特种医学 | 6篇 |
外科学 | 59篇 |
综合类 | 2篇 |
预防医学 | 9篇 |
眼科学 | 13篇 |
药学 | 14篇 |
肿瘤学 | 20篇 |
出版年
2024年 | 1篇 |
2023年 | 11篇 |
2022年 | 12篇 |
2021年 | 38篇 |
2020年 | 9篇 |
2019年 | 8篇 |
2018年 | 17篇 |
2017年 | 17篇 |
2016年 | 23篇 |
2015年 | 14篇 |
2014年 | 17篇 |
2013年 | 11篇 |
2012年 | 15篇 |
2011年 | 15篇 |
2010年 | 4篇 |
2009年 | 1篇 |
2008年 | 11篇 |
2007年 | 12篇 |
2006年 | 3篇 |
2005年 | 2篇 |
2004年 | 2篇 |
排序方式: 共有243条查询结果,搜索用时 15 毫秒
101.
102.
103.
104.
Dharmagat Bhattarai MD DM Pandiarajan Vignesh MD DM Himanshi Chaudhary MD Niteesh Bharadwaj MD Lokesh Saini MD DM Kirti Gupta MD Amit Rawat MD 《Pediatric dermatology》2020,37(6):1119-1124
Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) represents the spectrum of skin lesions characterized by rashes, exfoliation, and sloughing usually following drug intake. Occasionally, TEN-like cutaneous manifestations have also been described with systemic lupus erythematosus. Recognition of lupus in a child presenting with TEN-like skin changes is clinically challenging and requires a high degree of suspicion. We describe the case of a child who had epidermal necrolysis as the presenting feature of lupus and had severe neurological complications. TEN-like skin changes in association with severe neurological complications in pediatric lupus are uncommon. Lupus must be considered in the differential diagnosis of a child presenting with epidermal necrolysis with no provocative risk factors such as a history of exposure to medications. 相似文献
105.
Herve Tiriac Juan Carlos Bucobo Demetrios Tzimas Suman Grewel Joseph F. Lacomb Leahana M. Rowehl Satish Nagula Maoxin Wu Joseph Kim Aaron Sasson Shivakumar Vignesh Laura Martello Maria Munoz-Sagastibelza Jonathan Somma David A. Tuveson Ellen Li Jonathan M. Buscaglia 《Gastrointestinal endoscopy》2018,87(6):1474-1480
106.
Elizabeth N. Bearrick Vignesh Packiam Bimal Bhindi Christine M. Lohse John C. Cheville Ross J. Mason Matthew Tollefson Susan Harrington Haidong Dong Alexander S. Parker Stephen A. Boorjian R. Houston Thompson Bradley C. Leibovich 《Urologic oncology》2021,39(2):135.e1-135.e8
BackgroundClinical and pathological factors alone have limited prognostic ability in patients with metastatic clear cell renal cell carcinoma (ccRCC). Bim, a downstream pro-apoptotic molecule in the PD-1 signaling pathway, has recently been associated with survival in other malignancies. We sought to determine if tissue biomarkers including Bim, added to a previously reported clinical metastases score, improved prediction of cancer-specific survival (CSS) for patients with metastatic ccRCC.MethodsPatients with metastatic ccRCC who underwent nephrectomy between 1990 and 2004 were identified using our institutional registry. Sections from paraffin-embedded primary tumor tissue blocks were used for immunohistochemistry staining for Bim, PD-1, B7-H1 (PD-L1), B7-H3, CA-IX, IMP3, Ki67, and survivin. Biomarkers that were significantly associated with CSS after adjusting for the metastases score were used to develop a biomarker-specific multivariable model using a bootstrap resampling approach and forward selection. Predictive ability was summarized using a bootstrap-corrected c-index.ResultsThe cohort included 602 patients: 192 (32%) with metastases at diagnosis and 410 (68%) who developed metastases after nephrectomy. Median follow-up was 9.6 years (IQR 4.2–12.8), during which 504 patients died of RCC. Bim, IMP3, Ki67, and survivin expression were significantly associated with CSS after adjusting for the metastases score, and were eligible for biomarker-specific model inclusion. After variable selection, high Bim (hazard ratio [HR] = 1.44; 95% confidence interval [CI] 1.16–1.78; P <0.001), high survivin (HR = 1.35; 95% CI 1.08–1.68; P = 0.008), and the metastases score (HR = 1.13 per 1 point; 95% CI 1.10–1.16; P <0.001) were retained in the final multivariable model (c-index = 0.69).ConclusionWe created a prognostic model combining the clinical metastases score and 2 primary tumor tissue expression biomarkers, Bim and survivin, for patients with metastatic renal cell carcinoma who underwent nephrectomy. 相似文献
107.
Vignesh Sundararajan Fazlul H. Sarkar Thamil Selvee Ramasamy 《Cellular oncology (Dordrecht)》2018,41(3):223-252
Background
Recent advances in cancer biology have highlighted the relevance of exosomes and nanovesicles as carriers of genetic and biological messages between cancer cells and their immediate and/or distant environments. It has been found that these molecular cues may play significant roles in cancer progression and metastasis. Cancer cells secrete exosomes containing diverse molecules that can be transferred to recipient cells and/or vice versa to induce a plethora of biological processes, including angiogenesis, metastasis formation, therapeutic resistance, epithelial-mesenchymal transition and epigenetic/stemness (re)programming. While exosomes interact with cells within the tumour microenvironment to promote tumour growth, these vesicles can also facilitate the process of distant metastasis by mediating the formation of pre-metastatic niches. Next to their tumour promoting effects, exosomes have been found to serve as potential tools for cancer diagnosis and therapy. The ease of isolating exosomes and their content from different body fluids has led to the identification of diagnostic and prognostic biomarker signatures, as well as to predictive biomarker signatures for therapeutic responses. Exosomes can also be used as cargos to deliver therapeutic anti-cancer drugs, and they can be engineered to serve as vaccines for immunotherapy. Additionally, it has been found that inhibition of exosome secretion, and thus the transfer of oncogenic molecules, holds promise for inhibiting tumour growth. Here we provide recent information on the diverse roles of exosomes in various cellular and systemic processes governing cancer progression, and discuss novel strategies to halt this progression using exosome-based targeted therapies and methods to inhibit exosome secretion and the transfer of pro-tumorigenic molecules.Conclusions
This review highlights the important role of exosomes in cancer progression and its implications for (non-invasive) diagnostics and the development of novel therapeutic strategies, as well as its current and future applications in clinical trials.108.
109.
Samantha E. Halpern Alec McConnell Sarah B. Peskoe Vignesh Raman Oliver K. Jawitz Ashley Y. Choi Megan L. Neely Scott M. Palmer Matthew G. Hartwig 《American journal of transplantation》2021,21(3):1269-1277
Lungs from “nonideal,” but acceptable donors are underutilized; however, organ procurement organization (OPO) metrics do not reflect the extent to which OPO-specific practices contribute to these trends. We developed a comprehensive system to evaluate nonideal lung donor avoidance, or risk aversion among OPOs. Adult donors in the UNOS registry who donated ≥1 organ for transplantation between 2007 and 2018 were included. Nonideal donors had any of age>50, smoking history ≥20 pack-years, PaO2/FiO2 ratio ≤350, donation after circulatory death, or increased risk status. OPO-level risk aversion in donor pursuit, consent attainment, lung recovery, and transplantation was assessed. Among 83916 donors, 70372 (83.9%) were nonideal. Unadjusted OPO-level rates of nonideal donor pursuit ranged from 81 to 100%. In a three-tier system of overall risk aversion, tier 3 OPOs (least risk-averse) had the highest rates of nonideal donor pursuit, consent attainment, lung recovery, and transplantation. Tier 1 OPOs (most risk-averse) had the lowest rates of donor pursuit, consent attainment, and lung recovery, but higher rates of transplantation compared to tier 2 OPOs (moderately risk-averse). Risk aversion varies among OPOs and across the donation process. OPO evaluations should reflect early donation process stages to best differentiate over- and underperforming OPOs and encourage optimal OPO-specific performance. 相似文献
110.
Pandiarajan Vignesh Sagar Bhattad Manphool Singhal Surjit Singh 《Rheumatology international》2016,36(8):1191-1193
Epidemiological case definition of Kawasaki disease (KD) by the American Heart Association requires the presence of fever and four of the following: eye signs, oral mucosal changes, skin rashes, limb edema, and unilateral cervical lymphadenopathy. Incomplete KD is a well-known entity where there is lack of some of mucocutaneous features, and this occurs more often in infants. We report a 5-year-old boy with KD and giant coronary aneurysms, who presented only with fever and there is complete lack of skin and mucosal manifestations at presentation. 相似文献